#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Are we close to targeted treatments for Huntington’s disease? YES

Czech version

Authors: prof. MUDr. Jan Roth, CSc.
Authors‘ workplace: 1. LF UK a VFN v Praze ; Centrum extrapyramidových, onemocnění, Neurologická klinika, a Centrum klinických neurověd
Published in: Cesk Slov Neurol N 2020; 83/116(3): 240
Category: Controversions

Sources

Rodriguesa FB, Quinn L, Wild EJ. Huntington’s disease clinical trials. corner: january 2019. J Hunting Dis 2019; 8 : 115–125.
Smith AV, Tabrizi SJ. Therapeutic Antisense targeting of huntingtin. DNA Cell Biol 2020; 39(2): 154–158.
Scoles DR, Minikel EV, Pulst SM. Antisense oligonucleotides: a primer. Neurol Genet 20191; 5(2): e323.
Singh K, Roy I. Nucleic acid therapeutics in Huntington's disease. Recent Pat Biotechnol 2019; 13(3): 187–206.
Su Y, Renbao C, Huiming Y et al. CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease. J Clin Invest 2017; 127(7): 2719–2724.
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB et al. Phase 1–2a IONIS-HTTRx study site teams. Targeting Huntingtin Expression in patients with huntington's disease. N Engl J Med 2019; 380(24): 2307–2316.
Zain R, Smith CI. targeted oligonucleotides for treating neurodegenerative tandem repeat diseases. Neurotherapeutics 2019; 16(2): 248–262.

Labels

Paediatric neurology Neurosurgery Neurology

Primary progressive aphasia

Are we close to targeted treatments for Huntington’s disease? NO

Are we close to targeted treatments for Huntington’s disease? COMMENT

Cognitive disorders in children with epilepsy

Autoimmune encephalitis with negative anti-neuronal antibodies – clinical characteristics and available methods of antibody detection

APOE and BDNF as genetic risk markers for predicting the onset and development of cognitive deficits due to Alzheimer’s disease

Role of novel laboratory techniques in Niemann-Pick type C disease diagnostics

Headaches in pregnancy

Occurrence and risk factors of unprovoked epileptic seizures in ischaemic stroke patients

Validation of DYsphagia in MUltiple Sclerosis questionnaire – Czech version of DYMUS

Effect of a neuropalliative care intervention on quality of life in patients with progressive neurological disease – interventional study

Characteristics of a cohort of boys with Duchenne and Becker muscular dystrophies – a study from a single neuromuscular centre

Epidural application of steroids Part 2 – The quality of life of patiens before application

Glioblastoma grade IV – long-term survival

Stanovisko redakční rady k diskuzi o úrovni a směřování Cesk Slov Neurol N

Erratum

Informace vedoucího redaktora

Recenze

Impact of dementia on the trajectories of quality of life in older adults

Magnetic resonance spectroscopy metabolomics of cerebrospinal fluid in patients with multiple sclerosis, clinically isolated syndrome, other inflammatory brain diseases and controls

Focal epileptic seizure in a young female from South Korea

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 3

2020 Issue 3

Most read in this issue

#ADS_BOTTOM_SCRIPTS#